Acquisition of HYPERBARIC BUPIVACAINE, IT, 5MGML;4ML from Lab. Bluemed for ULSASI for the year 2026

This tender pertains to the acquisition of hyperbaric bupivacaine, specifically in the formulation of 5MGML;4ML, from the laboratory Bluemed. The procurement is intended for the ULSASI (Unidade Local de Saúde do Alto Sávio e Interior) for the year 2026. The tender outlines the need for a reliable supplier that can provide the specified pharmaceutical product, ensuring compliance with all relevant health and safety regulations. Key requirements may include the supplier's ability to deliver the product within the stipulated timeframe, adherence to quality standards, and the provision of necessary documentation to support the procurement process. The location of the service is within the jurisdiction of ULSASI, which operates in the healthcare sector. Interested parties are encouraged to review the tender specifications thoroughly to ensure they meet all criteria and can fulfill the contract requirements effectively. This procurement is essential for maintaining the quality of care provided by ULSASI and ensuring that healthcare professionals have access to the necessary medications for patient treatment.

This is a supplies contract in the information and communication technology sector. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 8,136.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the information and communication technology sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.